Supernus Statistics
NASDAQ: SUPNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
28.61+0.26 (+0.92%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Supernus by the numbers
Supernus has a market capitalization of $5.94 billion based on 207.72M shares outstanding. With trailing EPS of $-0.76, Supernus is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.2% below its 50-day average and 18.9% below its 200-day average.
Average daily trading volume is 2.77M shares, or about $79.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SUPN valuation vs. peer median
| Metric | SUPN | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.94B | $5.79B | +3% |
| Forward P/E | 7.1 | 29.7 | -76% |
| Avg. volume | 2.77M | 715.37K | +287% |
Peer median across 8 companies: ARWR, LGND, GRFS, MIRM, ABVX, BLTE, MANE, AXSM.
Valuation
- Market cap
- $5.94B
- Forward P/E
- 7.15
- Price / sales (latest FY)
- 8.27
- EPS (TTM)
- $-0.76
- Shares outstanding
- 207.72M
Price and trading
- Previous close
- 28.35
- Open
- 28.39
- Day range
- 28.15 – 29.51
- 52-week range
- 25.92 – 42.81
- 52-week change
- -36.87%
- Beta
- —
- Volume
- 2.83M
- Average volume
- 2.77M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 5.94B
- Forward Pe
- 7.15
- Eps
- -0.76
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 42.81
- Week52 Low
- 25.92
- Avg Volume
- 2.77M
- Shares Outstanding
- 207.72M
- Ma50
- 33.33
- Ma200
- 35.28
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -33.17%
- Pct From52w Low
- 10.38%